相关实验视频

Updated: Jul 1, 2025

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

多学科的方法和治疗状和粘膜黑色素瘤

Ana Fortuna¹, Teresa Amaral^2,3

¹Oncology Department, Centro Hospitalar Universitário do Algarve, Faro, Portugal.

Frontiers in oncology

|March 12, 2024

概括

和粘膜黑色素瘤是罕见的,具有独特遗传特征的侵袭性皮肤癌,包括KIT突变. 了解这些差异是改善治疗结果和克服对疗法的耐药性的关键.

科学领域:

在瘤学瘤学.
皮肤病学皮肤病学
遗传学是一个遗传学.

背景情况:

形黑色素瘤和粘膜黑色素瘤是不常见的黑色素瘤亚型.
与皮肤黑色素瘤相比,这些黑色素瘤表现出明显的生物学和临床特征.
它们的共同点是更具侵略性的性质和不太有利的预后.

研究的目的:

审查状和粘膜黑色素瘤的临床表现,病理和突变概况.
探索这些罕见的黑色素瘤变体的当前治疗策略和结果.
确定克服治疗耐药性的潜在方法.

主要方法:

关于状和粘膜黑色素瘤的文献综述.
对临床,病理和遗传数据的分析.
综合当前治疗结果和耐药性机制.

主要成果:

面和粘膜膜黑色素瘤的发病率不同,占所有黑色素瘤病例的很小比例.
这些亚型显示KIT突变的患病率更高.
基因基因突变可能导致预后较差和对免疫检查点抑制剂的耐药性.

结论:

由于其侵略性和独特的突变性景观,状和粘膜性黑色素瘤在黑色素瘤治疗中具有独特的挑战.
准KIT突变和开发新的治疗策略对于改善患者的治疗结果至关重要.
为了优化全身疗法,需要进一步研究耐药机制.

关键词:

在GNA11突变中.在GNAQ中发生突变.基因基因突变 KIT 突变这是一种状黑色素瘤.免疫疗法免疫疗法局部疗法局部疗法粘膜上的黑色素瘤有针对性的治疗.

更多相关视频

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

相关概念视频

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...